{"altmetric_id":7563787,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":31},"news":{"unique_users_count":1,"unique_users":["healio_com"],"posts_count":1},"twitter":{"unique_users_count":18,"unique_users":["ferlazjo","JHepatology","suganshiva","WybrichCnossen","Liver4Kids","tterizarbien","zenonmacias","DrChengJun","IlindelatorreMD","yanomani22","reigana","joaprimo","pierluigitarqui","hildersom","EASLnews","Elektra","PKD_Int","PKDCharity"],"posts_count":25},"facebook":{"unique_users_count":5,"unique_users":["286804811394378","621177498022649","147692597934","111174402293114","229886050511908"],"posts_count":5}},"selected_quotes":["no #UDCA benefit in advanced symptomatic PLD patients but decreased LCV growth in ADPKD","[In press] #UDCA not able to reduce #liver volume in patients with polycystic liver disease. The CURSOR trial","#Liver cyst volume growth reduced in pts receiving UCDA compared to pts with no treatment","UDCA for polycystic liver disease? Find our here"],"citation":{"abstract":"Ursodeoxycholic acid (UDCA) inhibits proliferation of polycystic human cholangiocytes in vitro and hepatic cystogenesis in a rat model of polycystic liver disease (PLD) in vivo. Our aim was to test whether UDCA may beneficially affect liver volume in patients with advanced PLD.\nWe conducted an international, multicenter, randomized controlled trial in symptomatic PLD patients from three tertiary referral centers. Patients with PLD and total liver volume (TLV) \u2a7e 2500mL were randomly assigned to UDCA treatment (15-20mg\/kg\/day) for 24 weeks, or to no treatment. Primary endpoint was proportional change in TLV. Secondary endpoints were change in symptoms and health-related quality of life. We performed a post-hoc analysis of the effect of UDCA on liver cyst volume (LCV).\nWe included 34 patients and were able to assess primary endpoint in 32 patients, 16 with autosomal dominant polycystic kidney disease (ADPKD) and 16 with autosomal dominant polycystic liver disease (ADPLD). Proportional TLV increased by 4.6 \u00b1 7.7% (mean TLV increased from 6697mL to 6954mL) after 24 weeks of UDCA treatment compared to 3.1 \u00b1 3.8% (mean TLV increased from 5512mL to 5724mL) in the control group (p=0.493). LCV was not different after 24 weeks between controls and UDCA treated patients (p=0.848). However, UDCA inhibited LCV growth in ADPKD patients compared to ADPKD controls (p=0.049).\nUDCA administration for 24 weeks did not reduce TLV in advanced PLD, but UDCA reduced LCV growth in ADPKD patients. Future studies might explore whether ADPKD and ADPLD patients respond differently to UDCA treatment.\nCurrent therapies for polycystic liver disease are invasive and have high recurrence risks. Our trial showed that the drug, ursodeoxycholic acid, was not able to reduce liver volume in patients with polycystic liver disease. However, a subgroup analysis in patients that have kidney cysts as well showed that liver cyst volume growth was reduced in patients who received ursodeoxycholic acid in comparison to patients who received no treatment.","altmetric_jid":"4f6fa4f53cf058f610002ddb","authors":["Hedwig M.A. D\u2019Agnolo","Wietske Kievit","R. Bart Takkenberg","Ioana Ria\u00f1o","Luis Bujanda","Myrte K. Neijenhuis","Ellen J.L. Brunenberg","Ulrich Beuers","Jesus M. Banales","Joost P.H. Drenth","D'Agnolo, Hedwig M A","Kievit, Wietske","Takkenberg, R Bart","Ria\u00f1o, Ioana","Bujanda, Luis","Neijenhuis, Myrte K","Brunenberg, Ellen J L","Beuers, Ulrich","Banales, Jesus M","Drenth, Joost P H"],"doi":"10.1016\/j.jhep.2016.05.009","endpage":"607","first_seen_on":"2016-05-17T22:57:56+00:00","funders":["niehs"],"issns":["1600-0641","01688278"],"issue":"3","journal":"Journal of Hepatology","last_mentioned_on":1488884229,"links":["http:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278%2816%2930195-7\/abstract?rss=yes","http:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(16)30195-7\/fulltext","http:\/\/dx.doi.org\/10.1016\/j.jhep.2016.05.009?sf33497167=1","https:\/\/secure.jbs.elsevierhealth.com\/action\/getSharedSiteSession?redirect=http:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(16)30195-7\/fulltext&rc=0&code=jhepat-site","http:\/\/dx.doi.org\/10.1016\/j.jhep.2016.05.009","http:\/\/www.journal-of-hepatology.eu\/article\/S0168-8278(16)30195-7\/fulltext#.WL6RwD0n8pM.facebook"],"pdf_url":"http:\/\/www.journal-of-hepatology.eu\/article\/S0168827816301957\/pdf","pmid":"27212247","pubdate":"2016-05-17T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"601","subjects":["gastroenterology"],"title":"Ursodeoxycholic acid in advanced polycystic liver disease: an international multicenter randomized controlled phase 2 trial","type":"article","volume":"65","mendeley_url":"http:\/\/www.mendeley.com\/research\/ursodeoxycholic-acid-advanced-polycystic-liver-disease-phase-2-multicenter-randomized-controlled-tri-2"},"altmetric_score":{"score":20.95,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":20.95},"context_for_score":{"all":{"total_number_of_other_articles":8320311,"mean":7.0122256031246,"rank":418055,"this_scored_higher_than_pct":94,"this_scored_higher_than":7901863,"rank_type":"exact","sample_size":8320311,"percentile":94},"similar_age_3m":{"total_number_of_other_articles":273758,"mean":11.729758486541,"rank":21763,"this_scored_higher_than_pct":92,"this_scored_higher_than":251977,"rank_type":"exact","sample_size":273758,"percentile":92},"this_journal":{"total_number_of_other_articles":2319,"mean":8.8591932700604,"rank":193,"this_scored_higher_than_pct":91,"this_scored_higher_than":2125,"rank_type":"exact","sample_size":2319,"percentile":91},"similar_age_this_journal_3m":{"total_number_of_other_articles":78,"mean":20.950649350649,"rank":21,"this_scored_higher_than_pct":73,"this_scored_higher_than":57,"rank_type":"exact","sample_size":78,"percentile":73}}},"demographics":{"poster_types":{"member_of_the_public":12,"researcher":1,"practitioner":4,"science_communicator":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":4,"Science communicators (journalists, bloggers, editors)":1,"Scientists":1,"Members of the public":12}},"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Researcher":1,"Other":2},"by_discipline":{"Medicine and Dentistry":2,"Chemistry":1,"Agricultural and Biological Sciences":1}}},"geo":{"twitter":{"EC":2,"CH":2,"IN":1,"NL":1,"US":2,"AR":1,"SG":1,"IT":1,"GB":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ferlazjo\/statuses\/732706648964354048","license":"gnip","citation_ids":[7563787],"posted_on":"2016-05-17T22:57:32+00:00","author":{"name":"Dr Fernando Lazo","image":"https:\/\/pbs.twimg.com\/profile_images\/1198141382\/Dr_Fernando_Lazo_normal.jpg","description":"Soy M\u00e9dico Cl\u00ednico Gastroenter\u00f3logo. trabajo en el Hospital de la Polic\u00eda Nacional de Guayaquil, Ecuador.","id_on_source":"ferlazjo","tweeter_id":"230291501","geo":{"lt":-2.20584,"ln":-79.90795,"country":"EC"},"followers":356},"tweet_id":"732706648964354048"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/733221072946991104","license":"gnip","citation_ids":[7563787],"posted_on":"2016-05-19T09:01:41+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6213},"tweet_id":"733221072946991104"},{"url":"http:\/\/twitter.com\/suganshiva\/statuses\/733221958528073728","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-05-19T09:05:12+00:00","author":{"name":"suganyashivakumar","image":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_4_normal.png","description":"A Doc, trainee in Medical Gastroenterology and Hepatology,coffee lover,opinionated,voracious reader ;","id_on_source":"suganshiva","tweeter_id":"76882684","geo":{"lt":20,"ln":77,"country":"IN"},"followers":63},"tweet_id":"733221958528073728"},{"url":"http:\/\/twitter.com\/WybrichCnossen\/statuses\/733225439917973505","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-05-19T09:19:02+00:00","author":{"name":"Wybrich Cnossen","image":"https:\/\/pbs.twimg.com\/profile_images\/705335309236641792\/KLPtGwG1_normal.jpg","description":"MD, PhD I Gastroenterology & Hepatology I Researcher I VNVA Board member","id_on_source":"WybrichCnossen","tweeter_id":"705326636380655617","geo":{"lt":52,"ln":5.25,"country":"NL"},"followers":34},"tweet_id":"733225439917973505"},{"url":"http:\/\/twitter.com\/Liver4Kids\/statuses\/733248426515791872","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-05-19T10:50:22+00:00","author":{"name":"Rohit Kohli","url":"http:\/\/www.chla.org\/KOHLI","image":"https:\/\/pbs.twimg.com\/profile_images\/872689377075384320\/cW6otPRq_normal.jpg","description":"Vocation: Advocate for #children afflicted by #liver and #gi problems: T\/RT opinion only","id_on_source":"Liver4Kids","tweeter_id":"2653582359","geo":{"lt":34.05223,"ln":-118.24368,"country":"US"},"followers":492},"tweet_id":"733248426515791872"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/733825155831463937","license":"gnip","citation_ids":[7563787],"posted_on":"2016-05-21T01:02:05+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6213},"tweet_id":"733825155831463937"},{"url":"http:\/\/twitter.com\/tterizarbien\/statuses\/733862909252489217","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-05-21T03:32:06+00:00","author":{"name":"Hepatitis C - Venez","image":"https:\/\/pbs.twimg.com\/profile_images\/464931735441256448\/q74MpP9y_normal.jpeg","description":"salud-bienestar-","id_on_source":"tterizarbien","tweeter_id":"2374304118","geo":{"lt":null,"ln":null},"followers":75},"tweet_id":"733862909252489217"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/734791782127403008","license":"gnip","citation_ids":[7563787],"posted_on":"2016-05-23T17:03:07+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6213},"tweet_id":"734791782127403008"},{"url":"http:\/\/twitter.com\/zenonmacias\/statuses\/735106937998675968","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-05-24T13:55:26+00:00","author":{"name":"Zenon Macias Jimenez","image":"https:\/\/pbs.twimg.com\/profile_images\/505003880896557056\/5F6zheM8_normal.jpeg","description":"M\u00e9dico-Gastroenterologo","id_on_source":"zenonmacias","tweeter_id":"373737932","geo":{"lt":-34.61315,"ln":-58.37723,"country":"AR"},"followers":220},"tweet_id":"735106937998675968"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/766158602390343680","license":"gnip","citation_ids":[7563787],"posted_on":"2016-08-18T06:23:40+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6213},"tweet_id":"766158602390343680"},{"url":"http:\/\/twitter.com\/DrChengJun\/statuses\/766159109611720704","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-18T06:25:40+00:00","author":{"name":"Dr. Cheng Jun","url":"http:\/\/about.me\/DrChengJun","image":"https:\/\/pbs.twimg.com\/profile_images\/660221950292135936\/_NNvvOlP_normal.png","description":"Gastroenterologist at Mount Elizabeth Medical Centre, Dr. Cheng Jun","id_on_source":"DrChengJun","tweeter_id":"3287761500","geo":{"lt":1.36667,"ln":103.8,"country":"SG"},"followers":62},"tweet_id":"766159109611720704"},{"url":"http:\/\/twitter.com\/IlindelatorreMD\/statuses\/766269535792029696","license":"gnip","citation_ids":[7563787],"posted_on":"2016-08-18T13:44:28+00:00","author":{"name":"Dr Ilin Gilberto dlT","image":"https:\/\/pbs.twimg.com\/profile_images\/836054970407452676\/xjxB0SNL_normal.jpg","description":"M\u00e9dico Internista. Frugal, amante de la lectura y de la tecnolog\u00eda #Internalmedicine Inscitia omnis arrogantiae mater est.","id_on_source":"IlindelatorreMD","tweeter_id":"17943376","geo":{"lt":-2,"ln":-77.5,"country":"EC"},"followers":20317},"tweet_id":"766269535792029696"},{"url":"http:\/\/twitter.com\/IlindelatorreMD\/statuses\/766270207174270977","license":"gnip","citation_ids":[7563787],"posted_on":"2016-08-18T13:47:08+00:00","author":{"name":"Dr Ilin Gilberto dlT","image":"https:\/\/pbs.twimg.com\/profile_images\/836054970407452676\/xjxB0SNL_normal.jpg","description":"M\u00e9dico Internista. Frugal, amante de la lectura y de la tecnolog\u00eda #Internalmedicine Inscitia omnis arrogantiae mater est.","id_on_source":"IlindelatorreMD","tweeter_id":"17943376","geo":{"lt":-2,"ln":-77.5,"country":"EC"},"followers":20317},"tweet_id":"766270207174270977"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/766798927517462528","license":"gnip","citation_ids":[7563787],"posted_on":"2016-08-20T00:48:05+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6213},"tweet_id":"766798927517462528"},{"url":"http:\/\/twitter.com\/DrChengJun\/statuses\/766800303849111553","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-20T00:53:33+00:00","author":{"name":"Dr. Cheng Jun","url":"http:\/\/about.me\/DrChengJun","image":"https:\/\/pbs.twimg.com\/profile_images\/660221950292135936\/_NNvvOlP_normal.png","description":"Gastroenterologist at Mount Elizabeth Medical Centre, Dr. Cheng Jun","id_on_source":"DrChengJun","tweeter_id":"3287761500","geo":{"lt":1.36667,"ln":103.8,"country":"SG"},"followers":62},"tweet_id":"766800303849111553"},{"url":"http:\/\/twitter.com\/yanomani22\/statuses\/766813416702959616","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-20T01:45:39+00:00","author":{"name":"Jon\u00e1sssssss","image":"https:\/\/pbs.twimg.com\/profile_images\/2162161793\/image_normal.jpg","id_on_source":"yanomani22","tweeter_id":"562159272","geo":{"lt":null,"ln":null},"followers":173},"tweet_id":"766813416702959616"},{"url":"http:\/\/twitter.com\/reigana\/statuses\/766814254938947584","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-20T01:48:59+00:00","author":{"name":"Reinaldo Garcia","image":"https:\/\/pbs.twimg.com\/profile_images\/3031058259\/303490a567b9b74901ffeafccb4160eb_normal.jpeg","id_on_source":"reigana","tweeter_id":"33374801","geo":{"lt":41.24117,"ln":-81.55262,"country":"US"},"followers":141},"tweet_id":"766814254938947584"},{"url":"http:\/\/twitter.com\/joaprimo\/statuses\/766927067258716160","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-20T09:17:16+00:00","author":{"name":"Joaqu\u00edn Primo","image":"https:\/\/pbs.twimg.com\/profile_images\/840124959968051201\/xMlS50zI_normal.jpg","description":"JUBILADO. Exjefe de Secci\u00f3n de Medicina Digestiva, Hospital de Sagunto","id_on_source":"joaprimo","tweeter_id":"558853052","geo":{"lt":null,"ln":null},"followers":326},"tweet_id":"766927067258716160"},{"url":"http:\/\/twitter.com\/pierluigitarqui\/statuses\/767452127778246660","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-21T20:03:40+00:00","author":{"name":"pierluigi tarquini","image":"https:\/\/pbs.twimg.com\/profile_images\/1519010412\/IMG_4203_2_normal.JPG","id_on_source":"pierluigitarqui","tweeter_id":"359973369","geo":{"lt":42.66123,"ln":13.69901,"country":"IT"},"followers":58},"tweet_id":"767452127778246660"},{"url":"http:\/\/twitter.com\/JHepatology\/statuses\/767765531281674240","license":"gnip","citation_ids":[7563787],"posted_on":"2016-08-22T16:49:01+00:00","author":{"name":"Journal Hepatology","url":"http:\/\/www.journal-of-hepatology.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/534704110344237057\/4oyP3BJQ_normal.png","description":"Official journal of @EASLnews   Geneva\/Switzerland - EASL does not express any political opinion -  RT \u2260 endorsement \n#hepatology #medicine #liver #healthcare","id_on_source":"JHepatology","tweeter_id":"862974992","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6213},"tweet_id":"767765531281674240"},{"url":"http:\/\/twitter.com\/hildersom\/statuses\/767806676133089280","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-22T19:32:31+00:00","author":{"name":"Hildersom","image":"https:\/\/pbs.twimg.com\/profile_images\/729441360256872448\/7dxqOGlc_normal.jpg","id_on_source":"hildersom","tweeter_id":"2798535789","geo":{"lt":null,"ln":null},"followers":33},"tweet_id":"767806676133089280"},{"url":"http:\/\/twitter.com\/EASLnews\/statuses\/767977794190053377","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-23T06:52:29+00:00","author":{"name":"EASLnews","url":"http:\/\/www.easl.eu","image":"https:\/\/pbs.twimg.com\/profile_images\/869091892885164032\/tvSr_K3w_normal.jpg","description":"EASL promotes #liver research & improves the treatment of #liverdisease accross the world. #hepatology\n____________\nEASL does not express any political opinion","id_on_source":"EASLnews","tweeter_id":"317662616","geo":{"lt":46.16667,"ln":6.16667,"country":"CH"},"followers":6330},"tweet_id":"767977794190053377"},{"url":"http:\/\/twitter.com\/Elektra\/statuses\/768171638177300480","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-23T19:42:45+00:00","author":{"name":"Tess Harris","url":"http:\/\/www.tessharris.com","image":"https:\/\/pbs.twimg.com\/profile_images\/781584403923296256\/mR57hgI1_normal.jpg","description":"Lifelong optimist. #PolyCyster @PKDCharity CEO. #NeoAthenian  @CiliaAlliance. @PKD_Int #RichardFeynman fan. Re-reading #GoreVidal post-Trump&Brexit","id_on_source":"Elektra","tweeter_id":"4547711","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":1068},"tweet_id":"768171638177300480"},{"url":"http:\/\/twitter.com\/PKD_Int\/statuses\/768171638194106368","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-23T19:42:45+00:00","author":{"name":"PKD International","url":"http:\/\/www.pkdinternational.org","image":"https:\/\/pbs.twimg.com\/profile_images\/907191923932319745\/yHxA1i___normal.jpg","description":"Global Alliance of #PKD Patient Groups promoting research and improved care for everyone affected by #ADPKD and #ARPKD","id_on_source":"PKD_Int","tweeter_id":"288375438","geo":{"lt":null,"ln":null},"followers":473},"tweet_id":"768171638194106368"},{"url":"http:\/\/twitter.com\/PKDCharity\/statuses\/768171638177292288","license":"gnip","rt":["JHepatology"],"citation_ids":[7563787],"posted_on":"2016-08-23T19:42:45+00:00","author":{"name":"PKD Charity UK","url":"http:\/\/www.pkdcharity.org.uk","image":"https:\/\/pbs.twimg.com\/profile_images\/781581597703151616\/9dUCsK3J_normal.jpg","description":"Seeking a Cure for Polycystic Kidney Disease. UK charity. Supporting patients, generating awareness, fundraising for research #ADPKD #ARPKD #polycystickidneys","id_on_source":"PKDCharity","tweeter_id":"57301080","geo":{"lt":54.75844,"ln":-2.69531,"country":"GB"},"followers":1747},"tweet_id":"768171638177292288"}],"facebook":[{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1135900413151476&id=286804811394378","license":"public","citation_ids":[7563787],"posted_on":"2016-08-17T13:00:18+00:00","summary":"Journal of Hepatology reports on \u201dUrsodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial\u201d. In this multicenter, randomized controlled trial, 34 patients with different types of polycystic liver disease","author":{"name":"GastroHepAdvance","url":"https:\/\/www.facebook.com\/286804811394378","facebook_wall_name":"GastroHepAdvance","image":"https:\/\/graph.facebook.com\/286804811394378\/picture","id_on_source":"286804811394378"}},{"title":"JOURNAL OF HEPATOLOGY","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=757069107766820&id=621177498022649","license":"public","citation_ids":[7563787],"posted_on":"2016-08-18T06:52:08+00:00","summary":"UDCA for polycystic liver disease?\n\nIn this multicenter, randomized controlled trial, 34 patients with different types of polycystic liver disease were treated with ursodeoxycholic acid (UDCA) or placebo. Results of liver cyst volume after 24 weeks of ther","author":{"name":"Fundaci\u00f3n Sayani","url":"https:\/\/www.facebook.com\/621177498022649","facebook_wall_name":"Fundaci\u00f3n Sayani","image":"https:\/\/graph.facebook.com\/621177498022649\/picture","id_on_source":"621177498022649"}},{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10154139004962935&id=147692597934","license":"public","citation_ids":[7563787],"posted_on":"2016-08-18T06:21:57+00:00","summary":"UDCA for polycystic liver disease?\n\nIn this multicenter, randomized controlled trial, 34 patients with different types of polycystic liver disease were treated with ursodeoxycholic acid (UDCA) or placebo. Results of liver cyst volume after 24 weeks of ther","author":{"name":"JOURNAL OF HEPATOLOGY","url":"https:\/\/www.facebook.com\/147692597934","facebook_wall_name":"Journal of Hepatology","image":"https:\/\/graph.facebook.com\/147692597934\/picture","id_on_source":"147692597934"}},{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1128541237223087&id=111174402293114","license":"public","citation_ids":[7563787],"posted_on":"2016-08-23T16:00:13+00:00","summary":"no #UDCA benefit in advanced symptomatic PLD #patients but decreased LCV growth in ADPKD \nhttp:\/\/buff.ly\/2brQyms","author":{"name":"EASL - The Home of Hepatology","url":"https:\/\/www.facebook.com\/111174402293114","facebook_wall_name":"EASL - The Home of Hepatology","image":"https:\/\/graph.facebook.com\/111174402293114\/picture","id_on_source":"111174402293114"}},{"title":"Liver Cysts - How I Approach It","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=733973570103151&id=229886050511908","license":"public","citation_ids":[7563787],"posted_on":"2017-03-07T10:57:09+00:00","summary":"Ursodeoxycholic acid in advanced polycystic liver disease: A phase 2 multicenter randomized controlled trial","author":{"name":"Gastroenterology Hepatology Endoscopy","url":"https:\/\/www.facebook.com\/229886050511908","facebook_wall_name":"Gastroenterology Hepatology Endoscopy","image":"https:\/\/graph.facebook.com\/229886050511908\/picture","id_on_source":"229886050511908"}}],"news":[{"title":"Ursodeoxycholic acid does not inhibit liver overgrowth","url":"http:\/\/ct.moreover.com\/?a=27724164824&p=1pl&v=1&x=jW-vo2-LRPxva7zi3HXwIA","license":"public","citation_ids":[7563787],"posted_on":"2016-08-24T16:43:09+00:00","summary":"Ursodeoxycholic acid may not be a viable treatment option for some patients with polycystic liver disease, according to research recently published in the Journal of Hepatology.","author":{"name":"Healio.com","url":"http:\/\/www.healio.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/968\/normal\/Screen_Shot_2015-04-10_at_13.36.33.png?1428669420"}}]}}